| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding | |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | Entrez:924 MIM:186820 HGNC:HGNC:1695 Ensembl:ENSG00000173762 AllianceGenome:HGNC:1695 | |
| Description | CD7 molecule | |||||
| GTO ID | GTC3055 |
| Trial ID | NCT05398614 |
| Disease | T-Cell Lymphoma | T-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SENL101 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies |
| Year | 2022 |
| Country | China |
| Company sponsor | Hebei Senlang Biotechnology Inc., Ltd. |
| Other ID(s) | SENL101 for CD7+ |
| Cohort 1 | |||||||||
|
|||||||||